KATHERINE LEMASTER: Open Payments
NPI 1265474423 · BEAUMONT, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$649 in 29 payments from 19 companies in 2025. Trend: 2023 $45 · 2024 $554 · 2025 $649
Food & beverage: $649
| Company | Payments | Amount |
|---|---|---|
| Celgene Corporation | 4 | $104 |
| PharmaEssentia USA Corporation | 3 | $54 |
| PFIZER INC. | 3 | $53 |
| SOBI, INC | 1 | $46 |
| Tempus AI, Inc | 2 | $45 |
| Merck Sharp & Dohme LLC | 2 | $45 |
| Astellas Pharma US Inc | 2 | $35 |
| Lilly USA, LLC | 1 | $30 |
| AstraZeneca Pharmaceuticals LP | 1 | $29 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $27 |
Products named: OPDIVO, BESREMI, OPDUALAG, Vonjo, XT CDX, KEYTRUDA, IBRANCE, VERZENIO.
Industry payments across TX — which companies pay providers there.
